← back to ranking

ARWR · Arrowhead Pharmaceuticals, Inc.

Biotechnology · mkt cap $10.0B · calls: Q2 FY2026 vs Q1 FY2026
3.0 conviction · conf-adj 3

conf –

triage_only:3.0

Enthusiasm latest / prev ()

No AI/ML; focus is RNAi drugs, launch, and trials.